Features | Partner Sites | Information | LinkXpress
Sign In
AMPRONIX
SCHILLER AG
TERARECON, INC.

New Research Shows CT Scanner’s Benefits Offset Cancer Risks in Young Adults

By Medimaging International staff writers
Posted on 20 Feb 2013
The underlying medical conditions facing young adults who undergo computed tomography (CT) scanning are representative of an appreciably greater health risk than that of radiation-induced cancer from CT, according to new findings.

The study’s findings were published online before print on February 5, 2013, in the journal Radiology. CT utilization has grown approximately 10% per year over the last 15 years in the United States, raising worries of an increase in radiation-induced cancers. However, discussions of radiation-induced cancer risk often fail to take into account the condition of the patients being imaged, according to Susanna Lee, MD, PhD, chief of women’s imaging at Massachusetts General Hospital (Boston, MA, USA) and assistant professor of radiology at Harvard Medical School (Boston, MA, USA). “The impetus for our study was the concern that the lay press often focuses on potential harm caused to patients by CT imaging,” Dr. Lee said. “Lacking in this discussion is a sense of how sick these patients already are.”

To better determine the pros and cons of CT in young adults, the researchers, led by Dr. Lee and researcher Robert L. Zondervan, MS, studied imaging records of patients 18 to 35 years old who underwent chest or abdominopelvic CT scans between 2003 and 2007 at one of three university-affiliated hospitals in Boston. Children and young adults are more susceptible to ionizing radiation and more likely to live for the approximately 10 to 20 years considered necessary to develop a radiation-induced malignancy.

The researchers had access to records from 22,000 patients, including 16,851 chest and 24,112 abdominopelvic CT scans. During the average 5.5-year follow-up period, 7.1% of young adults who underwent chest CT scanning, and 3.9% of those who had abdominopelvic CT died—statistics that were much greater than the 0.1% long-term risk of death from radiation-induced cancer predicted by statistical models in both groups. “It was a bit surprising to see how high the five-year mortality rate was in this group,” Dr. Lee said. “To put it in context, the average young adult has only a 1% chance of dying in the next five years.”

The most typical reasons for exam were cancer and trauma for chest CT, and abdominal pain and trauma, and cancer for abdominopelvic CT scanning. Whereas many of the patients who underwent CT were cancer patients with a poor prognosis, Dr. Lee noted that the key differences in risk were evident in the other groups who had CT imaging, such as those suffering from trauma, abdominal pain, and difficulty breathing. “When we subtracted out cancer patients from the data set, the risk of death in the study group ranged from 2.5%–5%—still well above the risk in the general population,” she said.

Dr. Lee and colleagues also discovered that the patients who were scanned only one or two times represented the overwhelming percentage of scans. “This finding shows that radiation reduction efforts should also focus on patients who are very rarely scanned, and not just those who are scanned repeatedly,” Dr. Lee said.

Dr. Lee noted that the study group was imaged between 2003 and 2007, before radiation dose awareness and reduction programs such as Image Wisely and Image Gently took effect. She reported that the risk of radiation-induced cancer from CT in all probability would be lower today, making the difference in mortality even more pronounced. “We’re not saying be complacent about the radiation risk from CT,” Dr. Lee added. “But these people being imaged might have been in a motor vehicle accident, or have a perforated appendix or life-threatening cancer, and we’re trying to gain information from scans that can help them. That’s the part that gets lost in the debate.”

Related Links:

Harvard Medical School




RADCAL
RTI ELECTRONICS AB
SuperSonic Imagine

Channels

MRI

view channel

Use of Breast MRI Offers Optimized Care

Magnetic resonance imaging (MRI) is being used increasingly for breast cancer screening, diagnostic assessment, treatment planning, and monitoring; however, a recent study revealed that over time, the indication for breast MRI has changed. Much of the increase was found among women with breast cancer risk factors, but there... Read more

Ultrasound

view channel
Image: Analogic Sonic Window handheld ultrasound for peripheral IV placement (Photo courtesy of Analogic).

First-of-a-Kind Ultrasound System Designed for Image-Guided Peripheral Intravenous Access and Fits in Pocket

A new, ultra-compact ultrasound device provides direct visualization of structures beneath the skin in real time to effectively guide clinicians placing peripheral intravenous (IV) lines.... Read more

Nuclear medicine

view channel
Image: Micrograph of Hodgkin lymphoma. Lymph node fine-needle aspiration (FNA) specimen. Field stain (Photo courtesy of Wikimedia Commons).

Early PET-Negative Stage I/II Hodgkin Lymphoma Patients Show Increased Risk of Early Relapse when Radiotherapy Is Not Used

Analysis of a new study indicates an increased risk of early relapse when excluding radiotherapy in early positron emission tomography (PET) scan-negative patients with stage I/II Hodgkin’s lymphoma.... Read more

General/Advanced Imaging

view channel

Secondary Light Emission Generated by Plasmonic Nanostructures May Improve Medical Imaging Technology

New clues into light emission at different wavelengths generated by elements known plasmonic nanostructures may help to improve medical imaging technology. A plasmon is a quantum of plasma oscillation. The plasmon is a quasiparticle resulting from the quantization of plasma oscillations just as photons, and phonons are... Read more

Imaging IT

view channel

Enterprise Image-Viewing System Receives FDA Clearance for Mobile Diagnosis on All Modalities

An enterprise image-viewing system is now cleared in the United States for diagnosis on mobile devices, for all imaging modalities (except mammography). Calgary Scientific, Inc. (Calgary, AB, USA) recently reported their latest Class II clearance from the US Food and Drug Administration (FDA). Calgary Scientific worked... Read more

Industry News

view channel

Collaboration Expands Capacity for Proton Therapy Clinical Research and Patient Treatments

Varian Medical Systems (Palo Alto, CA, USA) and the Paul Scherrer Institute (PSI; Villigen PSI, Switzerland) are extending an existing collaboration in the field of proton therapy to offer patients more accurate cancer treatments using intensity-modulated proton therapy (IMPT). Under the agreement, Varian will also... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.